Since mid-June, the Food and Drug Administration (FDA) has unobtrusively been accepting applications from government and private hospitals and clinics for cannabis sales licenses.
More than 200 have applied and got their licenses, mostly government hospitals.
But only a handful have started to treat patients with cannabis medication, due to an acute shortage of supply of CBD oil and THC oil, produced single-handedly by the Government Pharmaceutical Organization (GPO).
Even though the cannabis sales licenses, word by word, do not impose any restrictions on what forms of cannabis in various stages of production a licensee can sell, the licenses are strictly issued for medical purposes.
No recreational sales are envisioned. And the single form of cannabis the licensee can sell is cannabis medication authorized by the FDA.
Only hospitals and clinics are eligible to apply; there is no one else qualified. And those sanitariums must have on their payrolls and be staffed by doctors, dentists or pharmacists, specially trained in dispensing cannabis by the Department of Medical Services (DMS).
Four rounds of such training have turned out more than 800 cannabis-trained medical professionals, who are issued training certificates by the DMS and are required to be registered as authorized dispensers with the FDA.
Two more rounds of training to go this month and in September; seats have all been filled up months ago. Over 1,000 DMS-trained medical professionals will have graduated from this course.
Those doctors who miss the training will have to wait for an online training curriculum, currently under design.
Read more at cannabislaw.report